In vitro andin vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative Alain PierréTheresa A. DunnGhanem Atassi OriginalPaper Pages: 137 - 148
Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model P. M. LoadmanM. C. BibbyR. S. McElhinney OriginalPaper Pages: 149 - 158
Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors N. C. MunshiP. J. Loehrer Sr.L. H. Einhorn OriginalPaper Pages: 159 - 163
Difluorodeoxycytidine (dFdC) — gemcitabine: A phase I study Elizabeth A. PoplinThomas CorbettLaurence Baker OriginalPaper Pages: 165 - 170
Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer Rafael RosellJoan CarlesMiguel Martín OriginalPaper Pages: 171 - 175
Phase I study of mitonafide in solid tumors Manuel LlombartAndrés PovedaVicente Guillem OriginalPaper Pages: 177 - 181
A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion Abraham MittelmanCarmelo PuccioZalmen Arlin OriginalPaper Pages: 183 - 190
Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles Joseph KattanJean-Pierre DrozHélène Sancho-Garnier OriginalPaper Pages: 191 - 199
Phase II trial of fludarabine phosphate for adenocarcinoma of the pancreas Lary J. KiltonAl B. Benson IIILinda Weidner OriginalPaper Pages: 201 - 204
Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma Ephraim S. CasperGary K. SchwartzDavid P. Kelsen OriginalPaper Pages: 205 - 209
Phase II study of didemnin B in advanced colorectal cancer Dennie V. Jones Jr.Jaffer A. AjaniJames L. Abbruzzese OriginalPaper Pages: 211 - 213
Phase II trial of N-methylformamide in lung cancer Robert L. CodyJerome E. SeidRonald B. Natale OriginalPaper Pages: 215 - 216
A phase II study of interleukin-2 and interferon-alpha in head and neck cancer Stimson P. SchantzIsaiah DimeryRudolfo Morice OriginalPaper Pages: 217 - 223
A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinoma Brian R. MurphySusan M. RynardPatrick J. Loehrer OriginalPaper Pages: 225 - 230
A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse Tribhawan VatsGeorge BuchananJeffrey Krischer OriginalPaper Pages: 231 - 234